KAKarim Othman Abdelnaim

Karim Othman Abdelnaim

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Karim Othman Abdelnaim has a total of 43 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Infant mortality related to congenital heart disease in the United States, 1999–2025: trends, disparities, and projections to 2040

    by Amr Ibrahim, Alaa Eldeeb, Raveen Mujeeb, Alyaa Ahmed Ibrahim, Mohamed Elfeki, Mahmoud Tablawy, Krish Patel, Karim Othman Abdelnaim, Fizzah Ikram Ul Haq, Mohammed Elshiekh, et al.

    Introduction: Congenital heart disease remains a leading congenital cause of infant mortality in the United States despite major advances in diagnosis and neonatal care. This study evaluated national mortality trends from 1999 to 2025, examined sex and racial disparities, and projected future burden through 2040 using time-series forecasting. Methods: A retrospective CDC WONDER analysis examined U.S. infant (< 1 year) CHD mortality from 1999 to 2025 using ICD-10 codes Q20–Q26. Deaths listing CHD as underlying or contributing cause were included. Crude mortality rates (CMRs) per 100,000 with 95% CIs were calculated. Trends were evaluated using Joinpoint regression analysis to estimate annual percent change (APC) and average annual percent change (AAPC). Forecasts to 2040 used ARIMA and ETS models, stratified by sex and race/ethnicity. Results: From 1999 to 2025, 55,719 infant deaths related to CHD were recorded in the United States, 92.16% in medical facilities. The CMRs declined from 69.66 in 1999 to 46.44 in 2025 (AAPC − 1.32%) and is projected at 37.51 by 2040. Male mortality remained higher than female (54.86 vs. 52.04). NH Black infants had the highest mean mortality (71.87), while NH Asian/Pacific Islander infants showed the steepest decline (AAPC − 2.30%). Recent increases appeared in NH White infants after 2018 (APC 1.56%) and Hispanic infants after 2020 (APC 3.48%) overall. Conclusion: Infant CHD related mortality declined substantially from 1999 to 2025 and is projected to continue decreasing through 2040; however, persistent excess mortality in male, NH Black, and Hispanic infants underscores enduring demographic disparities in outcomes.

  • Trends in acute myocardial infarction mortality with diabetes mellitus as a contributing cause of death in the United States, 1999–2025, with forecasts through 2030 and exploratory projections for 2031–2040

    by Alyaa Ahmed Ibrahim, Youssef Ramadan, Alaa Eldeeb, Krish Patel, Youssef Shalaby, Ahmed Eldefrawy, Karim Othman Abdelnaim, Amr Ibrahim, Mohamed Alatfawy, Moustafa Ahmed Elsayed, et al.

  • Open Access

    Ischemic heart disease mortality with documented tobacco use in the United States, 1999–2023: a nationwide population-based analysis

    by Alyaa Ahmed Ibrahim, Zuha Tariq, Abdul Samad, Ahmed Khairy, Alaa Eldeeb, Maha Sajjad, Abdelrhman H. Mohamed, Walid Bechibchi, Mohamed Alatfawy, Karim Othman Abdelnaim, et al.

    Background: Tobacco use is a major risk factor for ischemic heart disease (IHD), substantially increasing the likelihood of myocardial infarction, stroke, and premature mortality. This study examined U.S. trends in IHD mortality with documented tobacco use disorder from 1999 to 2023. Methods: CDC mortality data for adults aged ≥ 25 years with IHD (ICD-10 codes: I20–I25) and documented tobacco use (ICD-10 code: F17) listed as contributing causes of death were analyzed. Age-adjusted mortality rates (AAMRs) per 100,000 population were calculated. Joinpoint regression was used to estimate annual percent change (APC) and average annual percent change (AAPC). Results: From 1999 to 2023, 1,497,919 deaths were reported. The AAMR rose from 3.90 to 32.37 (AAPC: 10.71; p < 0.01). Males had a higher AAMR (39.68; AAPC: 10.72) than females (14.05; AAPC: 10.77). Non-Hispanic (NH) Whites had the highest AAMR (26.86), followed by American Indians (25.43), NH Blacks (19.77), and Hispanics (10.38). The Midwest had the highest regional AAMR (32.96). Most deaths occurred in inpatient facilities (27.9%). Adults aged ≥ 65 years had the highest mortality rate (CMR: 92.16). Rural areas exceeded urban (35.73 vs. 22.95). Conclusion: IHD mortality with documented tobacco use has risen sharply, disproportionately affecting older adults, males, rural areas, the Midwest, and NH Whites.


  • Open Access

    Cardiogenic Shock and Sepsis-Related Mortality in the United States, 1999-2025: National Trends, Disparities, and Forecasts to 2040

    by Karim Othman Abdelnaim, Alaa Eldeeb, Alyaa Ahmed Ibrahim, Raveen Mujeeb, Mohammad Rayyan Faisal, Amro Ali, Salem Qupp, Bassam Hegazy, Amr Ibrahim, Ibtissam ElGhazzani, et al.

    Background: Cardiogenic shock (CS) complicated by sepsis is a life-threatening condition marked by circulatory collapse and systemic inflammation, with persistently high mortality despite critical care advances. National trends and disparities remain unclear. This study aimed to evaluate temporal mortality trends from 1999 to 2025 and project rates through 2040. Methods: We conducted a population-based study using U.S. mortality data (1999–2025) from the CDC WONDER database. Deaths among adults aged ≥25 years with CS and sepsis were identified using ICD-10 codes. Age-adjusted mortality rates (AAMRs) per 100,000 were calculated. Joinpoint regression estimated annual percent change (APC) and average annual percent change (AAPC). Forecasting models projected mortality trends through 2040. Results: From 1999 to 2025, 71,726 deaths occurred; 97.09% in medical facilities. Overall, AAMR rose from 0.65 to 2.16 (AAPC 5.01%, p < 0.001) and is projected to reach 3.62 by 2040. Men had higher mortality than women (2025: 2.78 vs 1.65; AAPC 5.06% vs 4.91%). In 2025, AAMR was 3.75 among NH Black individuals, 1.98 among NH White individuals, and 2.01 among Hispanic individuals. Adults ≥65 years had the highest CMR (7.50 in 2025; AAPC 4.63%), with the largest relative increase in ages 25–44 (AAPC 7.19%). Conclusion: CS with sepsis mortality increased significantly from 1999 to 2025, particularly among men, NH Black individuals, and adults ≥65 years. Although recent trends have stabilized, projections indicate continued increases through 2040, highlighting persistent and widening demographic disparities in the mortality burden.


  • Open Access

    Cardiac Arrest and Cardiomyopathy Related Mortality in the United States, 1999-2025: Trends and Disparities

    by Mahdi Ahmed, Alaa Eldeeb, Maryam Saghir, Alyaa Ahmed Ibrahim, Mohammad Rayyan Faisal, Raveen Mujeeb, Bassam Hegazy, Mohamed Zabady, Amr Ibrahim, Karim Othman Abdelnaim, et al.

    Background: Cardiac arrest and cardiomyopathy are major contributors to cardiovascular mortality and sudden death. However, long-term national mortality trends and demographic disparities remain unclear. This study aimed to evaluate U.S. mortality trends from 1999 to 2025 and assess differences by sex, race/ethnicity, and age. Methods: We conducted a cross-sectional analysis of U.S. mortality data from 1999–2025 using the CDC WONDER Multiple Cause-of-Death database. Deaths among adults aged ≥25 years were identified using ICD-10 codes I42 (cardiomyopathy) and I46 (cardiac arrest), including cases where these codes appeared as underlying or contributing causes of death. Age-adjusted mortality rates (AAMRs) per 100,000 population were calculated. Temporal trends were assessed using Joinpoint regression and expressed as average annual percent change (AAPC), stratified by sex, race/ethnicity, and three age groups (25–44, 45–64, and ≥65 years). Results: Between 1999 and 2025, 237,958 deaths from cardiac arrest and cardiomyopathy occurred among U.S. adults ≥25 years. Overall, AAMR declined from 6.33 to 2.41 (AAPC −3.83; 95% CI: −4.18 to −3.57). Males had higher mortality than females (AAMR 5.82 vs 2.71) with declines from 9.13 to 3.28 and 4.36 to 1.62, respectively. Non-Hispanic (NH) Black individuals had the highest AAMR (7.42), followed by Hispanics (4.62). Mortality was highest among those aged ≥65 years (CMR 14.74), declining from 23.88 to 7.88 between 1999 and 2025. Conclusion: Mortality from cardiac arrest and cardiomyopathy declined significantly from 1999–2025. However, substantial disparities persisted, with higher mortality among males, NH Black individuals, and adults ≥65 years, highlighting ongoing inequities in cardiovascular outcomes.